{"id":"W4405181612","doi":"10.1158/1538-8514.cancerchem24-a013","title":"Abstract A013: Prioritization of Eleven-Nineteen-Leukemia (ENL) inhibitors as orally available drug candidates for acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Leukemia; In vivo; Medicine; Cancer; Pharmacology; Drug; Cancer research; Acute leukemia; Potency; Immunology; In vitro; Biology; Internal medicine; Biochemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002327361,0.0004838158,0.0005049452,0.0004350943,0.0001587651,0.0005863752,0.0002858415,0.0002613405,0.005490558],"category_scores_gemma":[0.0001610638,0.0001343868,0.0002431916,0.00029297,0.0001348191,0.0002876853,0.0002624352,0.0006179759,0.0011934],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003864013,"about_ca_system_score_gemma":0.0005729437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007259059,"about_ca_topic_score_gemma":0.001639675,"domain_scores_codex":[0.9998821,0.00001628396,0.00001077422,0.00002240539,0.00004237281,0.00002619131],"domain_scores_gemma":[0.9999186,0.000008262223,0.00001795597,0.00000475136,0.000023652,0.00002680708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001354722,0.0004185297,0.0007999973,0.0003820046,0.00003887742,0.0002644572,0.00002576224,0.001116855,0.9331166,0.001161777,0.003467848,0.05785246],"study_design_scores_gemma":[0.0008195501,0.006887231,0.003435261,0.00007298555,0.0001591514,0.0007263873,0.0000443639,0.003463325,0.9354547,0.0002470265,0.04865085,0.00003925749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9240882,0.02427798,0.01474793,0.001568666,0.0004357835,0.001328491,0.003497292,0.0007724149,0.02928324],"genre_scores_gemma":[0.9517229,0.01181848,0.01461156,0.0006104496,0.00007867509,0.0002422012,0.003004268,0.00008829286,0.01782334],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005490558,"threshold_uncertainty_score":0.01836777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0107684843274228,"score_gpt":0.2777045741678547,"score_spread":0.2669360898404319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}